ArticleCureus2026
Synchronous Endometrioid Adenocarcinoma of the Ovary and Endometrium in a 37-Year-Old Nulligravid Woman: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synchronous primary malignancies of the endometrium and ovary are uncommon and require careful differentiation from metastatic disease due to differences in staging, management, and prognosis. We report the case of a 37-year-old nulligravid woman presenting with lower abdominal pain and long-standing menstrual irregularity. Imaging revealed a large left adnexal mass with endometrial thickening. Exploratory laparotomy with intraoperative frozen section suggested malignancy, following which comprehensive surgical staging was performed. Final histopathology confirmed synchronous primary endometrioid adenocarcinoma of the ovary (International Federation of Gynecology and Obstetrics (FIGO) IA, grade I) and endometrium (FIGO II, grade II) without nodal or peritoneal involvement. Immunohistochemistry supported independent primary tumors. The patient had an uneventful recovery. This case emphasizes the importance of thorough surgical staging and meticulous pathological evaluation in establishing synchronous primary disease and guiding appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.